Legend Biotech (LEGN) Other Working Capital Changes (2020 - 2025)
Legend Biotech (LEGN) reported Other Working Capital Changes of -$10.3 million for Q3 2025, up 39.29% on a YoY basis from -$7.4 million in Q3 2024, and down 9.3% quarter-over-quarter from -$9.5 million in Q2 2025.
Legend Biotech (LEGN) Other Working Capital Changes (2020 - 2025) Analysis & Trends
Legend Biotech has reported Other Working Capital Changes for 6 years, with the latest figure at -$10.3 million in Q3 2025.
- For the quarter ending Q3 2025, Other Working Capital Changes rose 39.29% year-over-year to -$10.3 million; the trailing twelve-month figure through Sep 2025 stood at -$45.9 million (down 22.34% YoY), and the FY2022 full-year result was -$50.6 million, down 4207.57% from the prior year.
- Other Working Capital Changes for Q3 2025 stood at -$10.3 million, down from -$9.5 million in the prior quarter.
- The five-year high for Other Working Capital Changes was $16.1 million in Q2 2021, with the low at -$50.6 million in Q4 2022.
- Historically, Other Working Capital Changes has averaged -$7.5 million across 5 years, with a median of -$5.6 million in 2021.
- Annual changes were most pronounced in 2023 — Other Working Capital Changes jumped 121.43% — and 2024, when it tumbled 135244.44%.
- Legend Biotech's Other Working Capital Changes stood at -$3.0 million in 2021, then slumped by 1606.47% to -$50.6 million in 2022, then surged by 100.02% to $9000.0 in 2023, then sank by 189433.33% to -$17.0 million in 2024, then jumped by 39.29% to -$10.3 million in 2025.
- The last three Other Working Capital Changes figures came in at -$10.3 million (Q3 2025), -$9.5 million (Q2 2025), and -$9.0 million (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Regeneron Pharmaceuticals | 63.43 Bn | 54.67 Bn | 3.31 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -10.35 Mn |
| Sep 30, 2025 | -10.35 Mn |
| Jun 30, 2025 | -9.47 Mn |
| Jun 30, 2025 | -9.47 Mn |
| Mar 31, 2025 | -9.04 Mn |
| Mar 31, 2025 | -9.04 Mn |
| Sep 30, 2024 | -17.04 Mn |
| Sep 30, 2024 | -17.04 Mn |
| Jun 30, 2024 | -8.29 Mn |
| Jun 30, 2024 | -8.29 Mn |
| Mar 31, 2024 | -12.18 Mn |
| Mar 31, 2024 | -12.18 Mn |
| Jun 30, 2023 | 9,000.00 |
| Jun 30, 2023 | 9,000.00 |
| Mar 31, 2023 | -9,000.00 |
| Mar 31, 2023 | -9,000.00 |
| Dec 31, 2022 | -50.61 Mn |
| Dec 31, 2022 | -50.61 Mn |
| Sep 30, 2022 | -40,000.00 |
| Sep 30, 2022 | -40,000.00 |